INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2012

Yeast glucopolysaccharide supplementation showed mixed effects on upper respiratory infection symptoms.

A randomized, double-blind, placebo-controlled trial evaluated 250 mg daily yeast-derived 1,3/1,6 glucopolysaccharide or placebo for 90 days in 100 healthy young adults, with 97 completing. The supplement tended to reduce total days with symptoms (198 days, 4.6%, versus 241 days, 5.5%; P = 0.06) and significantly improved the ability to breathe easily, though other severity scores did not differ. Monocyte chemotactic protein-1 was lower during infections with supplementation.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
100 healthy young adults (97 completed)
What was measured
Upper respiratory tract infection symptoms and plasma cytokines

THE PAPER

Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections.

Fuller R, Butt H, Noakes PS, Kenyon J, Yam TS, Calder PC. Nutrition, 2012.

PubMed 22465901 ↗DOI 10.1016/j.nut.2011.11.012 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.